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doctors general surgery conference (NUGSC)
3rd & 4th March 2012, at University College London
Joseph Yoav Dangoor, Abhiney Jain. UCL Medical School, United Kingdom.
The second NUGSC took place this year, and was attended by over 300 delegates. This annual event hosted a faculty of leading surgeons,
of whom Prof. Paolo Macchiarini was the International speaker. He is famous for his recent pioneering of stem-cell seeded tracheal
transplants.
The meeting explored the future of surgery in the UK, addressing concerns of medical students and junior doctors with an interest in the
career, and updating them on current issues.
The research exhibition was hosted by the Society of Academic and Research Surgeons (SARS), which awarded the following prizes:
 The SARS Prize for the best overall presentation of research awarded to: Miss Cissy Yong, UCL Medical School
 The Royal College of Surgeons of Edinburgh Prize for the best oral presentation of research
awarded to: Dr. Hanieh Asadi
 The NUGSC Prize for the best poster presentation of research awarded to: Stuart Stokes, Shefﬁeld Medical School
 The British Orthopaedic Association National Undergraduate Prize for the best orthopaedic research presentation awarded
to: Mr Mahiben Maruthappu, University of Oxford School of Medicine1 Presenting author: Dr. David MaskellTHE USE OF MITEK BONE ANCHORS FOR SYNTHETIC MESH FIXATION
TO REPAIR RECALCITRANT ABDOMINAL HERNIAS
Ali Ali. Cambridge University Medical School, United States
Introduction: Repair of recurrent abdominal hernias is a surgical chal-
lenge which usually presents to the plastic surgeon as a last resort. Such
recalcitrant hernias cause enormous morbidity and constitute a ﬁnancial
burden to any health service. It is important to explore novel and poten-
tially effective repair methods. We report on a technique utilising overlay
prolene mesh ﬁxed to bone using Mitek anchors.
Methods: All patients who had Mitek bone anchor ﬁxation of synthetic
mesh, to repair recurrent iatrogenic abdominal hernias between 2003 and
2010 by one surgeon (CMM) were retrospectively reviewed. The indica-
tions, operative details and clinical outcomes were documented.
Results: The seven patients (6F, 1M) were aged 35 to 60 (average 53) years.
The causes of herniationwere incisional (4) and abdominal ﬂap harvests (3).
They had had a median of three hernia repairs before referral to plastic
surgery. The operations lasted a mean of 6 hours (range 3e10½ hrs). There
were no major intra and post-operative problems although one patient
requested removal of two of his eight Mitek anchors because of persistent
localisedpain and tenderness. After amean followupof 24months (range4e
34 months) only one patient developed a recurrent lower abdominal bulge.
Conclusion: Our single operator series demonstrated that Mitek bone
anchor ﬁxation of prosthetic mesh reinforcement of abdominal wall hernia
repair is an effective treatment technique associated with a lowmorbidity.
This method of recalcitrant hernia repair may be a useful addition to the
plastic surgeon's armamentarium.
NO SCAR TOO FAR?
Dr.AshleyScrimshire,Mr.A.Abdelrazeq,Mr.R.Rajaganeshan,Dr.A.Mannesso,
Miss. K. Hancorn.Mersey Foundation School (FY1), United Kingdom
Introduction: Natural oriﬁce transluminal endoscopic surgery (NOTES)
involves using natural oriﬁces such as the mouth, vagina or rectum insteadof opening the abdominal wall. This means the patient is left with no
visible scar and may reduce post-operative pain. Currently these tech-
niques are only experimental, but it is possible NOTES may develop to
become an alternative surgical practice.
Aims: We aim to ﬁnd the opinion of the public and medical professionals
on NOTES.
Methods: An information sheet and an anonymous questionnaire were
distributed to participants, who included inpatients, medical professionals
andmembers of the public. Questionnaires were then collected and results
analyzed.
Results: A total of 106 questionnaires were analyzed (55% male). Medical
professionalsmade39%.Morewomenthought theappearanceof theabdomen
after surgerywasvery important (50%vs40%). Both sexeswereundecidedas to
whether this type of surgery was a step too far. Of the patients who had
previous surgery 80% of the laparoscopic group preferred NOTES compared
with69%of theopengroup.But interestingly65%of the laparoscopicgroupand
only 50%of theopengroup felt this type of surgerywas a step too far.When the
responses from the clinicians were analysed, 75% of the surgeons felt strongly
against having no visible scar, but only 3% of the medics felt this way.
Conclusions: With technology rapidly transforming surgical practice,
advances sometimes lag behind what is acceptable for patients. We as
clinicians must make sure the risks of new technology are openly and
honestly debated.
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ABSTRACTSBackground: Both orthopaedic surgery and cast immobilisation are
independent risk factors for development of VTE1. There are currently no
guidelines on appropriate risk stratiﬁcation or treatment for this cohort of
patients2. The potentially signiﬁcant ﬁnancial cost of prophylaxis has
previously not been established.
Aims: To perform an economic analysis to determine the potential costs
and beneﬁts of the above treatment.
Methods: Data from one hundred patients who had undergone lower limb
immobilisation were prospectively collected using a specially designed
proforma. Information included personal demographics, diagnosis and
adjusted risk factors for VTE.
A decision tree model from a NHS perspective was used to calculate both
cost of prophylaxis and cost of VTE diagnosis, treatment and long term
complications. Incremental cost-effectiveness ratios (ICER) were calcu-
lated to provide estimates of the cost per VTE averted, and cost per quality-
adjusted life year (QALY) gained with the use of thromboprophylaxis.
Discussion 46/100 patients with primary lower limb cast immobilisation
qualiﬁed for prophylaxis. This numberof patientswould incur a prophylaxis
cost of £9113.52, however would save an estimated £3617.44 in direct VTE
diagnosis and treatment costs and £19,847.10 in long-term costs. This
resulted in a cost per VTE averted of £3338.10 and cost perQALYof £9623.58.
There are substantial cost implications in using thromboprophylaxis for
cast immobilised patients, however it has been demonstrated that this
may be cost effective in the long term. Using a more selective risk strati-
ﬁcation tool may reduce direct prophylaxis costs and increase short term
cost effectiveness.
SYMPTOMS SUGGESTIVE OF DUMPING SYNDROME AFTER PROVOCATION
IN PATIENTS AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY
Dimitris Papamargaritis a, George Tzovaras a, Eleni Sioka a, Eleni Zachari a,
Ioannis Baloyiannis a, Dimitris Zacharoulis a, George Koukoulis b.
aDepartment of Surgery, University Hospital of Larissa, Greece; bDepartment
of Endocrinology, University Hospital of Larissa, Greece
Background: Dumping syndrome is a well-known complication after
upper gastrointestinal (GI) surgery. There are scarce data in the literature
about the incidence of dumping after bariatric operations but, certainly no
relation between this syndrome and laparoscopic sleeve gastrectomy
(LSG) has been attempted.
Methods: We conducted a prospective clinical study in order to evaluate
the potential presence, incidence and severity of Dumping syndrome after
LSG. Thirty one non-diabetic morbidly obese patients (eight male, 23
female) eligible for LSG were evaluated. Median age was 38 (22e58 years)
and mean body mass index (BMI) was 45.55 (5.37). The diagnosis of
dumping syndrome was based on clinical provocation of signs and
symptoms using an oral glucose challenge before and 6 weeks after the
operation. The Sigstad's dumping score was estimated in order to separate
dumpers from non-dumpers, and the Arts questionnaire was completed to
distinguish between early and late dumping. Moreover, blood glucose
levels during the oral glucose challenge were measured.
Results: No patient had symptoms of dumping after provocation preop-
eratively, whereas after LSG 9 patients (29%) experienced deﬁnite
dumping and other 5 patients (16%) symptoms suggestive of dumping
syndrome. Arts’ questionnaire demonstrated that dumping occurrence
after LSG was associated with early symptoms. Late hypoglycaemia
occurred in one patient.
Conclusion: A signiﬁcant proportion of patients after LSG experienced
dumping syndrome upon provocation. It seems that LSG should no longer
be considered as a pure restrictive procedure, and it might be an option for
heavy sweeters by changing their food tolerance patterns.
APPEARANCES CAN BE DECEIVING e GENETIC HETEROGENEITY IN THE
COLON OF CANCER PATIENTS
E. Day a,b, F. McCaughan a, A. Ibrahim c, M. Arends c, P.H. Deara a. aMRC
Laboratory of Molecular Biology, Cambridge, United Kingdom; bUniversity of
Cambridge School of Clinical Medicine, United Kingdom; cDepartment of
Pathology, University of Cambridge, United Kingdom
Background: Distinct histological features physically deﬁne a colorectal
carcinoma (CRC) and distinguish it from the normal colon mucosa. Often,however, there are regions adjacent to a carcinoma that deviate from the
normal histological appearance and display features of hyperplasia and/or
adenoma. It is not certain whether these regions represent precursor
lesions or reactive changes. To address this we have characterised a series
copy number alterations (CNAs) that typify CRC in the regions adjacent to
a carcinoma.
Methods: Micro-dissection molecular copy number counting (mMCC) was
used to assay CNAs frequently observed in CRC and those known to
contribute to carcinogenesis. mMCC employs laser capture micro-dissec-
tion to accurately collect DNA from speciﬁc histological regions and uses
single molecule digital PCR to measure copy number. Four CRC cases were
characterised.
Results: In the normal colon we describe genetic heterogeneity and
identify CNAs that are known to contribute to tumour formation, namely
KRAS ampliﬁcation. In addition a number of copy number changes are
shared by and built on in the hyperplastic, adenomatous and carcinoma
samples.
Conclusion: These preliminary data support the model of step-wise
cancer progression but importantly suggest that nearby hyperplastic
regions may represent precursors rather than reactive changes. These
results have implications on our understanding of CRC pathogenesis and
practically on the optimal location of resection boundaries in CRC surgery.
Further work is now needed to establish how widespread CNAs are in the
normal colon and regions adjacent to CRC.
THE QUALITY OF REPORTING IN RANDOMISED CONTROLLED TRIALS IN
PLASTIC SURGERY
Eric Edison. UCL Medical School, United Kingdom
Introduction: Randomised controlled trials (RCTs) represent the gold
standard in evaluating healthcare interventions. However, RCTs can yield
biased results if they lack methodological rigour, especially where surgical
techniques are involved. Readers need complete, clear and transparent
information. The Consolidated Standards of Reporting Trials (CONSORT)
statement for non-pharmacological interventions was developed to aid
reporting and consists of a 23 essential items.
Aim: To assess the compliance of RCTs in Plastic Surgery with the
CONSORT statement.
Method: Medline was searched by an information specialist from 1
January 2009 to 30 June 2011 for the MESH heading “Surgery, Plastic”with
limitations for English language, human studies and randomised
controlled trials. Results were then manually searched for relevant RCTs
involving surgical techniques. These were scored against the 23 item
CONSORT checklist. Secondary scoring was then performed and discrep-
ancies resolved by consensus.
Results: 55 papers involving 3,830 patients met the inclusion criteria from
a manual search of 254 papers retrieved from Medline. The average
CONSORT score was 11.5 out of 23 items (50%, range 5.3e21.0). Compliance
was poorest with items related to intervention/comparator details (7%),
randomisation implementation (11%) and blinding (26%). There was no
link between journal 2010 impact factor and CONSORT score (R ¼ 0.25).
Only 60% declared conﬂicts of interest and 75% had permission from an
ethics committee.
Conclusion: The reporting quality of RCTs in Plastic Surgery is poor.
Importantly, those aspects central to RCT methodology (randomisation
and blinding) were the most poorly reported.
FUNCTIONAL HEALTH STATUS OF PATIENTS AFTER THE FONTAN
OPERATION
Hanieh Asadi General Medicine Diploma work a,b,1. aDepartment of
Pediatric Cardiothoracic Surgery, Comenius University in Bratislava Medical
Faculty, Slovakia; b The National Institute of Cardiovascular Diseases, Comenius
University in Bratislava Medical Faculty, Slovakia
Background: The Fontan procedure is a palliative procedure for the single
ventricle, existing for about four decades. A retrospective study was made
